Target intelligence / Profile preview

Mitochondrial kinetoplast DNA (kDNA) (kDNA)

Target
kDNA
Molecular classification
Other, Nucleic acid
01

Overview

Mitochondrial kinetoplast DNA (kDNA) is a massive, complex network of interlocked circular DNA molecules located within the single mitochondrion of kinetoplastid parasites, such as Leishmania and Trypanosoma species (Jensen, R. E., & Englund, P. T. (1998). The kinetoplast DNA of Trypanosoma brucei. Annual Review of Microbiology). This unique structure consists of two types of DNA: maxicircles, which encode essential mitochondrial proteins, and thousands of minicircles, which encode guide RNAs required for the extensive RNA editing of maxicircle transcripts (Shapiro, T. A., & Englund, P. T. (1995). The structure and replication of kinetoplast DNA. Annual Review of Microbiology). Because kDNA is vital for the parasite's energy metabolism and has no structural equivalent in mammalian cells, it is a highly selective target for chemotherapy (Cavalcanti, D. P., & de Souza, W. (2018). The Kinetoplast of Trypanosomatids. In: Trypanosomatids). Several clinically used drugs, including pentamidine and diminazene, are known to accumulate within the kinetoplast and bind to the minor groove of the DNA, leading to the condensation or loss of the kDNA network (Werbovetz, D. B. (2006). Diamidines as antitrypanosomal agents. Current Opinion in Investigational Drugs). The resulting "dyskinetoplasty" prevents the synthesis of functional mitochondrial enzymes, ultimately leading to parasite death. Consequently, kDNA remains a focal point for developing new treatments against diseases like leishmaniasis and Chagas disease.

Other names
Kinetoplast DNAkDNA networkMitochondrial DNA of trypanosomatids
02

Mechanism of action

Minor groove binding to AT-rich regions, inhibition of mitochondrial topoisomerase II, and induction of kDNA loss (dyskinetoplasty).

03

Biological functions

OtherMitochondrial gene expressionRNA editingParasite replicationEnergy metabolism
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityHepatotoxicityInjection site reactionsDrug resistance
06

Interacting drugs

Pentamidine

3 more in the full profile.

07

Biomarkers

kDNA PCR for parasite detectionkDNA minicircle quantification

Beyond the preview

Go deeper on Mitochondrial kinetoplast DNA (kDNA) (kDNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial kinetoplast DNA (kDNA) (kDNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call